Your browser doesn't support javascript.
loading
del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma.
Corre, Jill; Perrot, Aurore; Caillot, Denis; Belhadj, Karim; Hulin, Cyrille; Leleu, Xavier; Mohty, Mohamad; Facon, Thierry; Buisson, Laure; Do Souto, Laura; Lannes, Romain; Dufrechou, Stephanie; Prade, Naïs; Orsini-Piocelle, Frederique; Voillat, Laurent; Jaccard, Arnaud; Karlin, Lionel; Macro, Margaret; Brechignac, Sabine; Dib, Mamoun; Sanhes, Laurence; Fontan, Jean; Clement-Filliatre, Lauriane; Marolleau, Jean-Pierre; Minvielle, Stephane; Moreau, Philippe; Avet-Loiseau, Hervé.
Afiliación
  • Corre J; Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France.
  • Perrot A; Centre de Recherche en Cancérologie de Toulouse, INSERM U1037, Toulouse, France.
  • Caillot D; Centre de Recherche en Cancérologie de Toulouse, INSERM U1037, Toulouse, France.
  • Belhadj K; Department of Hematology, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France.
  • Hulin C; Department of Hematology, University Hospital, Dijon, France.
  • Leleu X; Department of Hematology, University Hospital, Creteil, France.
  • Mohty M; Department of Hematology, University Hospital, Bordeaux, France.
  • Facon T; Department of Hematology, University Hospital, Poitiers, France.
  • Buisson L; Hematology and Cellular Therapy Department, Saint-Antoine University Hospital, Sorbonne University, and INSERM UMRs 938, Paris, France.
  • Do Souto L; Department of Hematology, University Hospital, Lille, France.
  • Lannes R; Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France.
  • Dufrechou S; Centre de Recherche en Cancérologie de Toulouse, INSERM U1037, Toulouse, France.
  • Prade N; Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France.
  • Orsini-Piocelle F; Centre de Recherche en Cancérologie de Toulouse, INSERM U1037, Toulouse, France.
  • Voillat L; Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France.
  • Jaccard A; Centre de Recherche en Cancérologie de Toulouse, INSERM U1037, Toulouse, France.
  • Karlin L; Department of Hematology, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France.
  • Macro M; Department of Hematology, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France.
  • Brechignac S; Department of Hematology, Departmental Hospital, Annecy, France.
  • Dib M; Department of Hematology, Departmental Hospital, Chalon, France.
  • Sanhes L; Department of Hematology, University Hospital, Limoges, France.
  • Fontan J; Department of Hematology, University Hospital, Lyon, France.
  • Clement-Filliatre L; Department of Hematology, University Hospital, Caen, France.
  • Marolleau JP; Department of Hematology, University Hospital, Bobigny, France.
  • Minvielle S; Department of Hematology, University Hospital, Angers, France.
  • Moreau P; Department of Hematology, Departmental Hospital, Perpignan, France.
  • Avet-Loiseau H; Department of Hematology, University Hospital, Besancon, France.
Blood ; 137(9): 1192-1195, 2021 03 04.
Article en En | MEDLINE | ID: mdl-33080624
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cromosomas Humanos Par 17 / Proteína p53 Supresora de Tumor / Deleción Cromosómica / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cromosomas Humanos Par 17 / Proteína p53 Supresora de Tumor / Deleción Cromosómica / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos